Thymosin-β4 is a determinant of drug sensitivity for Fenretinide and Vorinostat combination therapy in neuroblastoma
Cheung, Belamy B., Tan, Owen, Koach, Jessica, Liu, Bing, Shum, Michael S.Y., Carter, Daniel R., Sutton, Selina, Po'uha, Sela T., Chesler, Louis, Haber, Michelle, Norris, Murray D., Kavallaris, Maria,Volume:
9
Language:
english
Journal:
Molecular Oncology
DOI:
10.1016/j.molonc.2015.04.005
Date:
August, 2015
File:
PDF, 3.62 MB
english, 2015